Navigation Links
Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares

BOSTON, Feb. 14, 2012  /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the Company's Board of Directors has completed the retirement of one hundred fifty million (150,000,000) common shares held by its officers and directors in exchange for Series B Convertible Preferred Shares. The common shares held by the officers and directors have now been cancelled and returned back to the Company treasury. This transaction represents a reduction of approximately 22% of the Company's issued and outstanding common shares.

The retirement of common shares by the Company's officers and directors will allow for greater flexibility to utilize the assets of Solos for debt reduction, future financing, and services. The Company intends to use proceeds from future financing for the development of new instrument lines as well as further enhancements to its MammoView® instrument line.

"This share retirement allows Solos to maintain the integrity of its market while continuing to develop its new product line.  Management believes in our progress and is willing to take a long term position in the Company's Series B Preferred Shares," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. is Primed for Growth in 2012
2. Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView® Instrument Line
3. Solos Endoscopy Finishes the 3rd Quarter With a Net Profit
4. Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market
5. Solos Endoscopy Goes Google
6. Solos Endoscopy Finishes the 3rd Quarter Strong
7. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
8. Solos Endoscopy to Market its MammoView® Breast Endoscopy Components to US Hospitals
9. Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales
10. Solos Endoscopy to Reduce Debt by Over $620,000
11. Solos Endoscopys MammoView® System Proves Crucial to Early Breast Cancer Detection
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... of the "Self Administration of High Viscosity ... ) has announced the addition of ... report to their offering. --> ... the addition of the "Self Administration of ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... gatherings where preparing the perfect dish and pleasing the palates of attendees is ... or bringing a dish to a seasonal get-together, give these recipes a try ...
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article ... more and more widely heralded as a breakthrough for performing hernia repairs. The article ... traditional laparoscopic surgery is that it can greatly reduce the pain that a patient ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... and athletic programs, launches new Wimbledon Athletics Facebook page to educate ... athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of 25 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) ... plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion of ... Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for his ...
Breaking Medicine News(10 mins):